David Norris, MD
Dermatology
Locations
Practice Locations
UCHealth Dermatology Clinic - Anschutz Medical Campus
1665 Aurora Ct, 3rd Floor, Anschutz Cancer Pavilion, Aurora, CO 80045720-848-0500
Provider Expertise
Clinical Interest for Patients
I am interested in treating autoimmune skin diseases (vitiligo, alopecia areata, lupus erythematosus), immunobullus diseases, psoriasis, acne, skin cancer, melanoma and cutaneous lymphoma and pigmentary disorders.
Specialties
- Dermatology ( 1974 )
Education & Training
Medical Schools
MD, Duke University School of Medicine (1973)
Undergraduate Schools
BA, Johns Hopkins University (MD) (1969)
Internships
Ohio State University Hospital Program (1974)
Residency Program
University of Colorado (1977)
University of Colorado (University Hospital) Program (1977)
Fellowships
Duke University Hospital Program (1972)
Duke University Hospital Program (1973)
Duke University Hospital Program (1973)
Professional Memberships
American Academy of Dermatology, Member
American Association Advancement of Science, Member
American Dermatologic Association, Member
American Federation of Clinical Research, Member
American Society of Clinical Investigation, Member
Research & Grants
Research Interests for Patients
As Chairman of the Department of Dermatology at the University of Colorado School of Medicine. He is an internationally renowned investigator in cutaneous immunology and cell biology, and melanoma research. He has been continuously funded for 40 years by the NIH, studying mechanisms of cell death in photosensitive lupus, vitiligo, and alopecia areata and has made seminal discoveries regarding the role of ultraviolet light in inducing translocation of autoantigens to the plasma membrane in keratinocytes in photosensitive lupus. His interest in immune mechanisms in vitiligo lead to many years of research in pigment cell biology, which eventually developed into studies of the resistance of melanocytes and melanoma to apoptosis. Over the past 17 years, Dr. Norris has been funded by a VA Merit Award to study drug combinations that kill melanoma by overcoming anti-apoptotic defenses, especially in melanoma initiating cells, and recently served on the Board of Scientific Councilors to the NCI Director.
information for referring providers
Referral Contact Phone
(720) 848-0500
Referral Contact Fax
720-848-0489
Clinical Interests for Referring Providers
Melanoma and Skin Cancer, Cutaneous T Cell Lymphoma, Psoriasis, Bulbous Disorders, Vitiligo and Pigmentary Disorders, Hair Loss, Alopecia Areata